Detection of novel biomarkers of liver cirrhosis by proteomic analysis. - Wikidata - awgldk - TriplyDB

Detection of novel biomarkers of liver cirrhosis by proteomic analysis.

Detection of novel biomarkers of liver cirrhosis by proteomic analysis.

http://www.wikidata.org/entity/Q33954802

about

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?Non-invasive diagnosis of liver fibrosis and cirrhosis.Elastin in the Liver Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort Non invasive tools for the diagnosis of liver cirrhosis.Non-invasive markers for hepatic fibrosis Proteomic profiling of HBV infected liver biopsies with different fibrotic stages.Hepatic fibrosis.Proteomic analysis of the hepatic tissue of Long-Evans Cinnamon (LEC) rats according to the natural course of Wilson disease.Lipogenesis is decreased by grape seed proanthocyanidins according to liver proteomics of rats fed a high fat diet.Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.Non-alcoholic fatty liver disease proteomics Identification and validation of potential new biomarkers for prostate cancer diagnosis and prognosis using 2D-DIGE and MS.Enzyme-linked immunosorbent assay characterization of basal variation and heritability of systemic microfibrillar-associated protein 4.Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions.Transcriptional analysis identifies key genes involved in metabolism, fibrosis/tissue repair and the immune response against Fasciola hepatica in sheep liver.Proteomic analysis of an immortalized mouse pancreatic stellate cell line identifies differentially-expressed proteins in activated vs nonproliferating cell states.Proteomic analysis of a rat pancreatic stellate cell line using liquid chromatography tandem mass spectrometry (LC-MS/MS).In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach.Proteomics approaches to fibrotic disorders.Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation.Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.Growth of Murine Splenic Tissue Is Suppressed by Lymphotoxin β-Receptor Signaling (LTβR) Originating from Splenic and Non-Splenic Tissues.A dynamic plasma membrane proteome analysis of alcohol-induced liver cirrhosis.Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation.Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients.Proteomics and liver fibrosis: identifying markers of fibrogenesis.Quantitative Proteomic analysis on Activated Hepatic Stellate Cells reversion Reveal STAT1 as a key regulator between Liver Fibrosis and recovery.Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers.Biomarkers of liver fibrosis.Molecular serum markers of liver fibrosis.Serum proteomics in biomedical research: a systematic review.Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies.An integrated proteomic and transcriptomic approach to understanding azathioprine- induced hepatotoxicity in rat primary hepatocytes.Protein-protein interaction network analysis of cirrhosis liver disease.Mass spectrometry-based quantitative proteomic profiling of human pancreatic and hepatic stellate cell lines.Plasma membrane proteome analysis of the early effect of alcohol on liver: implications for alcoholic liver disease.Association between microfibrillar-associated protein 4 (MFAP4) and micro- and macrovascular complications in long-term type 1 diabetes mellitus.Myofibroblasts are important contributors to human hepatocellular carcinoma: evidence for tumor promotion by proteome profiling.

P2860

Q26744631-04263C5F-CFF6-43F5-AFF7-905F4FADB89C Q26778033-887AD93E-9F8E-471B-9912-073AF6A8EDA2 Q28077991-A3A5FFA4-9D26-4A43-9509-9C77301F6869 Q28550209-F21A2E66-C2B0-4AB1-8A9E-4442632CA16B Q30421450-99A1BB84-83FF-4CD9-8E76-9E43E5F811DC Q30474093-BE251507-C45E-4D64-AE8C-C67FDA1CFD90 Q33587550-17F4904E-A0C1-4A6B-AE07-C1C5CEB283EB Q33904174-E7DD3F08-40AD-4B56-85B7-4837DBE6F4A5 Q33959613-4BAF8806-1415-460A-8AB8-F0CDA698E801 Q34122121-F715F3AA-B153-40AD-8F0E-ED4412D5D8EE Q34345002-80E2EEB5-0569-4EF2-8F1B-2745C1D6D534 Q34578790-00F3171F-7BFC-4593-B15D-72A936D18305 Q35033878-DD8CDC6B-D37A-49DE-86C0-4995AA3FB8F0 Q35064164-C7535357-1CEE-4349-A79F-1DD7FAF71CB3 Q35070100-C401C228-A277-45DD-984F-EF994882514D Q35246561-752CDC47-2B14-48F7-996F-C1D3151FB2A5 Q35292565-F929290F-B83C-440C-B03A-0345407D34A1 Q35613951-C35F279F-D075-438F-BBDF-4992662BA361 Q35722244-2A223E9E-0C71-4BE8-840A-C710FAF338FC Q36012560-90F89ADA-A36F-46F1-8861-08880EE15F31 Q36069506-4D4DB901-DDB6-4EB7-895B-5032378D26C4 Q36156172-E427D9B7-DD64-4D4D-B67F-6563C9B9FF67 Q36217780-149E07C0-7EC0-44AB-9ECF-F04A679D5BFB Q36571861-FE4FE026-D080-4B40-9B52-4256607845F6 Q36745088-A27C156E-8E7F-4148-B2FA-50C07C1F90F8 Q36836214-B9FEF8B1-DABD-438F-B8DE-DCD50D69DFD1 Q37064540-C8F5B7D9-E996-41BB-87C2-E505B0260744 Q37579910-BC4E6707-3700-466E-A097-ED35780FED6E Q37713034-3AC526FB-3A46-47BD-86BA-1D6ABB51F7DF Q37824721-D15EA9E5-C91F-4942-BCCF-5C77F87224C2 Q37825547-FBD8D57D-E164-416E-B20B-14A19B03805D Q38032835-8C361FEF-C183-4700-A40D-41262947E3BA Q38101008-FB1931CF-2207-4C5E-82B6-9FAE7914BD4D Q38384848-DF2207C4-9DDF-4889-B6DE-1161061B78CA Q38443595-1FAE35AF-CC5C-40D9-9EC2-FF1D07BDA8DC Q38448298-EA21BA04-2560-4E77-B299-6F3C57968445 Q38491316-32C868E2-FE84-4A5C-807B-1F0E609FE690 Q38504104-CA574606-5BD9-42C5-B33B-9AE3C03D16C4 Q39048316-EF5A1BEF-E334-4046-AA96-D4E2C37625C4 Q39335058-FD6C3F93-1180-4C97-9685-9C05ACD836A2

P2860

Detection of novel biomarkers of liver cirrhosis by proteomic analysis.

http://www.wikidata.org/entity/Q33954802

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Detection of novel biomarkers of liver cirrhosis by proteomic analysis.

@ast

Detection of novel biomarkers of liver cirrhosis by proteomic analysis.

@en

type

label

Detection of novel biomarkers of liver cirrhosis by proteomic analysis.

@ast

Detection of novel biomarkers of liver cirrhosis by proteomic analysis.

@en

prefLabel

Detection of novel biomarkers of liver cirrhosis by proteomic analysis.

@ast

Detection of novel biomarkers of liver cirrhosis by proteomic analysis.

@en

P1433

Q33954802-A373BBD6-1697-45EF-84FF-637BB0E02959

P1476

Q33954802-CC92E3FA-F2CA-454B-A9FC-E6CDA99761FB

P2093

Q33954802-27F750CD-3670-4C00-AFAC-3048F6B9EAC5

Q33954802-57D77DDE-DA8E-48BE-92DF-90865EA817BC

Q33954802-72808BE5-DFD8-4750-9F03-B5CA7842E03C

Q33954802-92C05546-E785-4B3F-9117-42E8EDCFD4EC

Q33954802-96C94858-4842-4889-858D-84DE9D304A01

Q33954802-99ABCFF8-9E1B-4AD9-A84D-9164E407F806

Q33954802-9B50686D-B264-406B-9A63-148A1408DE20

Q33954802-B54E6A84-B5E0-49F7-A737-074E1E208E53

Q33954802-B8CC012B-6163-4938-BECB-3FFD2485D2AF

Q33954802-BB9A115F-34FC-46D4-A422-8381E949BF5A

P2860

Q33954802-0A3B2FD3-7D72-49BD-8CF6-49DB73B24C93

Q33954802-0F202AF7-85C2-4DCE-928D-56214836D010

Q33954802-1777C481-7C17-486E-83E1-1F8AD48179D2

Q33954802-28B4BBE1-8A91-4034-AFB5-0302711CA2E3

Q33954802-2B60FA15-1A15-4AF0-8F15-D1CC844358A8

Q33954802-433F7961-C814-4731-A47F-2B195BF669A7

Q33954802-4E24D3D5-32C2-400A-9EC8-F6D3CFE0EA27

Q33954802-5BDB3711-A2E1-4716-8336-623FB090A32B

Q33954802-65002E48-B213-48A2-B613-19CE7E7E0860

Q33954802-753EACA4-46BA-4326-A447-196AF81B4513

P304

Q33954802-45C63831-A02B-4F67-B71E-BCC99916F907

P31

Q33954802-E26AE08A-B1E4-4415-914E-29BCA805357E

P356

Q33954802-91478AEB-B693-49E0-8E15-8400CC8DDE6A

P407

Q33954802-9DF6CBD9-76F5-46BE-80B8-D1300265AB67

P433

Q33954802-2C263759-0964-4EA0-9E61-A05CFCB2F524

P478

Q33954802-6E063D2F-31D3-4066-A370-6E695F349750

P50

Q33954802-5C9BD014-BC77-44F3-9FF8-F8A6EE2F0C7E

Q33954802-8D93871C-EECE-4600-8D6F-3B07CEEA639B

Q33954802-DE0CDC38-2CF9-4A8C-84F5-B6C3F95AFA0F

Q33954802-F19D322B-9126-4CC3-9038-601BE44440E8

P577

Q33954802-19E7FCB9-74FD-4C2C-942F-0D34A56F5848

P5875

Q33954802-608ABC55-2104-42BB-BDD0-A6FA3DEF04C1

P698

Q33954802-08A3F564-DB93-43CF-9597-753EB3636AD8

P921

Q33954802-ACA7E91A-5FE8-4AE7-96A1-D8C47B55A8B3

Q33954802-B09D43D5-2E8F-4B1A-88B8-062E0AE854EE

P932

Q33954802-E9045486-F958-4B30-AEF2-58FD411B1711

P356

P1433

P1476

Detection of novel biomarkers of liver cirrhosis by proteomic analysis.

@en

P2093

Anders Schlosser

http://www.w3.org/2001/XMLSchema#string

Barbara Sitek

http://www.w3.org/2001/XMLSchema#string

Christian Mölleken

http://www.w3.org/2001/XMLSchema#string

Christoph Broelsch

http://www.w3.org/2001/XMLSchema#string

Corinna Henkel

http://www.w3.org/2001/XMLSchema#string

Gereon Poschmann

http://www.w3.org/2001/XMLSchema#string

Helmut E Meyer

http://www.w3.org/2001/XMLSchema#string

Ida Tornøe

http://www.w3.org/2001/XMLSchema#string

Kai Stühler

http://www.w3.org/2001/XMLSchema#string

Markus Reiser

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of a stellate cell activation-associated protein (STAP) with peroxidase activity found in rat hepatic stellate cells

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

Probability-based protein identification by searching sequence databases using mass spectrometry data

Integrins: versatility, modulation, and signaling in cell adhesion

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Microfibril-associated protein 4 is present in lung washings and binds to the collagen region of lung surfactant protein D

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

Epidemiology of hepatitis C: geographic differences and temporal trends

Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

P304

1257-1266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22764

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Bettina Warscheid

Günter Klöppel

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23957760

http://www.w3.org/2001/XMLSchema#string

P698

19177598

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

2895500

http://www.w3.org/2001/XMLSchema#string